Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $62.99 Analyst target: $107.26 Upside: 70.28%
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.